February 27, 2007

EuropaBio Press Release

EuropaBio Press Release: EU Institutions Press for Early Adoption of Advanced Therapies Regulation

EuropaBio Background Briefing

EuropaBio Advanced Therapies Q&A

EuropaBio Advanced Therapies Policy Brief

Advanced Therapies poster
 

EuropaBio background

EuropaBio Press Release: Biotech industry welcomes outcome of Parliament’s ENVI vote on Advanced Therapies Medicinal Products Regulation

Biographies of speakers

Useful documents

JRC study: Human tissue-engineered products - Today's markets and future prospects

Report from Dr. Mikolasik, Rapporteur EP Environment Committee

Report on EuropaBio November 2006 Policy Forum on Advanced Therapies

Programme
 

12.15   Welcome and Introduction
Michael Leader, Director, Healthcare Council

12.25   The Commission view  
Martin Terberger, Head of Unit,  Pharmaceuticals, European Commission

12:35   Presentation of the Draft Report and the ENVI vote     
Miroslav Mikolasik, Member European Parliament

12:45   Overview, industry perspective
Wills Hughes-Wilson
Chair of EuropaBio Advanced Therapies Working Group

12:55   View from the German Presidency

Walter Schwerdtfeger, Deputy General Director, Medicinal Products, Medical Devices & Biotechnology,
German Ministry of Health

13.05   The patient perspective:
Access to treatments and ethical issues
Flaminia Macchia,
European Public Affairs Officer, EURORDIS

13.15   The company perspective        
Gil Beyen, CEO Tigenix

13:25   Q & A

Moderated by Michael Leader, Director, Healthcare Council

13.50   Close